Breaking News

 Current Happenings in Medicine, Research, Devices, Equipment, and Other MS Treatments

These pages contain links to top stories from a multitude of sites in that topic area. There will be a few sentences from the article first and if you want to read more there will be a ‘more’ link to redirect you to the source of the information.


For April 2017

From: National MS Society:

FDA Approves Ocrevus™ (ocrelizumab) for People with Primary Progressive MS or Relapsing MS — First Disease-Modifying Therapy for Primary Progressive MS -MORE-

From: Multiple Sclerosis Association of America:

FDA Approves First Drug to Treat Two Forms of MS.On March 28, 2017, the United States Food and Drug Administration (FDA) announced the approval of Ocrevus™ (ocrelizumab) for the treatment of two types of multiple sclerosis (MS): relapsing forms of MS (RMS) and primary-progressive MS (PPMS). This is the first time that a medication for MS has been approved for two types of the   – MORE –

From MS International Federation: